Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Prostatic Neoplasms × Morphine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 11 Cancer Pain 10 Pain 8 Pain, Postoperative 5 Agnosia 4 Colonic Neoplasms 3 Neoplastic Cells, Circulating 2 Mucositis 2 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Leukemia, Biphenotypic, Acute 2 Colorectal Neoplasms 2 Chronic Pain 2 Breakthrough Pain 2 Waldenstrom Macroglobulinemia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thrombocythemia, Essential 1 Supratentorial Neoplasms 1 Stomach Neoplasms 1 Signs and Symptoms 1 Sezary Syndrome 1 Reperfusion Injury 1 Prostatic Neoplasms 1 Primary Myelofibrosis 1 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Postoperative Complications 1 Polycythemia Vera 1

Interventions

Docetaxel 144 Prednisone 108 Leuprolide 81 enzalutamide 69 Radiotherapy 69 bicalutamide 68 Goserelin 66 Abiraterone Acetate 65 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 47 Zoledronic Acid 36 Magnetic Resonance Spectroscopy 34 Estramustine 28 abiraterone 27 gallium 68 PSMA-11 26 apalutamide 26 Flutamide 26 radium Ra 223 dichloride 24 Radiosurgery 22 Gonadotropin-Releasing Hormone 21 Dutasteride 20 Androgen Antagonists 20 sipuleucel-T 19 cabazitaxel 19 Surveys and Questionnaires 18 Radiation 18 Exercise 17 Brachytherapy 17 luprolide acetate gel depot 16 Triptorelin Pamoate 16 Prednisolone 16

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01367418 2012-03-19

AIMS

Örebro University, Sweden

Phase 3 Completed

Inflammation, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡